Chronic dietary tyrosine supplements do not affect mild essential hypertension

Area of Science:

• Cardiovascular Research
• Nutritional Science
• Pharmacology

Background:

• Mild essential hypertension is a prevalent condition requiring effective management strategies.
• Norepinephrine plays a role in blood pressure regulation.
• Tyrosine is the biochemical precursor to norepinephrine.

Purpose of the Study:

• To investigate the effect of oral tyrosine supplementation on blood pressure and plasma norepinephrine levels in patients with mild essential hypertension.
• To determine if tyrosine supplementation can be a beneficial dietary addition for managing hypertension.

Main Methods:

• A randomized, double-blind, crossover study was conducted.
• 13 untreated patients with mild essential hypertension received oral tyrosine (2.5 g t.i.d.) or placebo for 2-week periods, separated by 2-week washout intervals.
• Blood pressure and plasma norepinephrine levels were measured at baseline and after each treatment period.

Main Results:

• Plasma tyrosine levels significantly increased after supplementation (p < 0.001).
• No significant differences were observed in systolic, diastolic, or mean blood pressure, heart rate, or plasma norepinephrine levels between tyrosine supplementation and placebo periods.
• Individual changes in blood pressure did not correlate with changes in norepinephrine levels.

Conclusions:

• Oral tyrosine supplementation does not appear to have a beneficial effect on blood pressure in individuals with mild essential hypertension.
• The study suggests that tyrosine supplementation is not an effective strategy for managing mild hypertension.
• Further research may be needed to explore other nutritional interventions for hypertension.